Genome
PRECISE, Temus form center to support Singapore’s genome program’s Phase III
Singapore's national precision-medicine agency (PRECISE) and Temasek-backed technology firm Temus will jointly build the data and computing systems for the next phase of the country's effort to sequence hundreds of thousands of residents' genomes.
